Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02376465 · ClinicalTrials.gov registry record · Phase 2
A Pilot Evaluation of an Experimental BLI4600 Formulation for Bowel Preparation in Adult Patients Undergoing Colonoscopy
A Phase 2 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT02376465 is a Phase 2 study that has completed, run by Braintree Laboratories. The registered enrollment target is 45 participants.
The verdict
NCT02376465, a Phase 2 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
To evaluate the safety, tolerance and efficacy of BLI4600 in multiple dosing regimens as a bowel preparation prior to colonoscopy in adult patients.
Interventions
- DRUG BLI4600 bowel preparation
- DRUG PEG based bowel preparation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2015-01 |
| Est. Completion | 2015-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02376465
The ClinicalTrials.gov registry entry for NCT02376465 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Braintree Laboratories, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BLI4600 bowel preparation is the first listed.
NCT02376465 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02376465 about?
NCT02376465 is a clinical study titled "A Pilot Evaluation of an Experimental BLI4600 Formulation for Bowel Preparation in Adult Patients Undergoing Colonoscopy". To evaluate the safety, tolerance and efficacy of BLI4600 in multiple dosing regimens as a bowel preparation prior to colonoscopy in adult patients.
What is the current status of trial NCT02376465?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2015-01. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02376465?
The interventions under investigation include: BLI4600 bowel preparation (DRUG), PEG based bowel preparation (DRUG).
Who is sponsoring clinical trial NCT02376465?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.